MYC and melanoma: Intriguingly, these genes that were downregulated in response to the RC48 and dabrafenib treatment, and were also observed to be overexpressed and associated with poor prognosis in melanoma TCGA cohort, were also components of the most enriched pathways identified by GSEA (E2F and MYC).